| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $131.2M | +15.9% |
| Cost of Revenue | $83.0M | -5.0% |
| Gross Profit | $48.2M | +87.0% |
| R&D Expense | $66.7M | +52.2% |
| SG&A Expense | $56.7M | +76.4% |
| Operating Income | -$128.1M | -46.4% |
| Interest Expense | $8.8M | -7.1% |
| Pre-tax Income | -$135.0M | -7.1% |
| Income Tax | $2.1M |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $490.8M | +589.4% |
| Accounts Receivable | $44.4M | -5.8% |
| Current Assets | $551.5M | +339.7% |
| Total Assets | $821.4M | +105.7% |
| Current Liabilities | $132.0M | +21.3% |
| Total Liabilities | $173.2M | -40.6% |
| Stockholders' Equity | $648.2M | +503.0% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.2M | -948.2% |
| Capital Expenditures | $10.3M | -60.5% |
| Investing Cash Flow | -$25.1M | +18.3% |
| Financing Cash Flow | $489.2M | +482.8% |
| Free Cash Flow | -$52.5M | -74.4% |
| +96.6% |
| Net Income | -$137.1M | -7.9% |
| EPS (Basic) | -$1.72 | +40.1% |
| EPS (Diluted) | -$1.72 | +40.1% |